Author of

• 20192

  +

  P3.13 - Radiology/Staging/Screening (ID 729)

  • Event: WCLC 2017
  • Type: Poster Session with Presenters Present
  • Track: Radiology/Staging/Screening
  • Presentations: 1
  • Moderators:
  • Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)

  • 24158

    +

    P3.13-006 - Correlation between CT Morphology at the Diagnosis and EGFR Status in Patients with Adenocarcinoma of the Lung (ID 8192)

    09:30 - 09:30  |  Presenting Author(s): Manlio Mencoboni
    • Abstract
    • Slides

    Background:
    Aim of the study was to correlate epidermal growth factor (EGFR) mutation status with computed chest tomography (CT) image patterns at the diagnosis in patients with lung adenocarcinoma.
    
    Method:
    Patients diagnosed between January 1, 2015 and March 3, 2017 with available CT and EGFR mutation status were analyzed. The maximal diameter of the nodules, shape (mix, solid) , presence of an air bronchogram and calcification, specula, incision, round shape, central necrosis, pleural connection, UH pre e post were evaluated.
    
    Result:
    87 patients (52 males, median age 66 years, range 43-87) were enrolled. 9, 36 and 42 patients had stage II, III and IV, respectively. EGFR mutations were found in 22 patients (25.3%; 1 exon 18, , 15 exon 19 deletions and 6 exon 21 mutations) and were more frequently among females (45.2% versus 18.6% males, p=0.020) and never smokers (77.8% vs 11.8% smokers, p<0.001). The median maximal diameter of the nodules was smaller in mutated patients (30.5, range 15-74 mm) than in wild-type patients (45.0, range 13-110 mm; p=0.010). Tumors with exon 21 mutations were smaller than wild type tumors (p=0.014). Mutations were statistically more frequent in solid pattern (30.6% vs 0 mixt, p=0.010). A higher number of mutations, not statistically significant, were also found in presence of tumors with regular margins (31.9% vs 17.5% spiculati, p=0.14), no incisions (30% vs 5.9% with incision, p=0.059), no central necrosis or calcification (26.3% vs 14.3% with central necrosis or calcification, p=0.67), no calcification (26.3% vs 14.3% with calcification, p=0.67). Median tumor density was 35 UH in wild type vs 40.0 UH in mutated tumors (p=0.29) and 70 UH in wild type vs 80 UH in mutated tumors (p=0.17), before and after contrast, respectively.
    
    Conclusion:
    Adenocarcinomas with EGFR mutations were associated with smaller tumors and with solid pattern.
    
    

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.